发布求助
文献互助 智能选刊 最新文献

Clinical pharmacology and therapy最新文献

筛选
英文 中文
Comparison of the three liquid metered dose inhalers technique in patients with COPD and bronchial asthma 三种液体计量吸入器技术在慢性阻塞性肺病和支气管哮喘患者中的比较
Clinical pharmacology and therapy Pub Date : 2023-05-21 DOI: 10.32756/0869-5490-2023-2-21-26
I. Vizel’, A. I. Rezyapova, A. Vizel’
{"title":"Comparison of the three liquid metered dose inhalers technique in patients with COPD and bronchial asthma","authors":"I. Vizel’, A. I. Rezyapova, A. Vizel’","doi":"10.32756/0869-5490-2023-2-21-26","DOIUrl":"https://doi.org/10.32756/0869-5490-2023-2-21-26","url":null,"abstract":"In respiratory medicine, the correct inhaler technique determines the clinical efficacy of inhaled medications.","PeriodicalId":10353,"journal":{"name":"Clinical pharmacology and therapy","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90143748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current diagnosis and treatment of arterial hypertension induced by antiangiogenic antitumour agents 抗血管生成抗肿瘤药物致动脉高血压的诊断与治疗现状
Clinical pharmacology and therapy Pub Date : 2023-05-21 DOI: 10.32756/0869-5490-2023-2-32-36
E. Shavarova, E. Khachaturyan, I. Pokatayev, Z. Kobalava
{"title":"Current diagnosis and treatment of arterial hypertension induced by antiangiogenic antitumour agents","authors":"E. Shavarova, E. Khachaturyan, I. Pokatayev, Z. Kobalava","doi":"10.32756/0869-5490-2023-2-32-36","DOIUrl":"https://doi.org/10.32756/0869-5490-2023-2-32-36","url":null,"abstract":"The use of angiogenesis inhibitors (anti-VGEF antibodies and tyrosine kinase inhibitors) in oncology significantly increases both the tumor response to therapy and the risk of cardiovascular toxicity. Arterial hypertension is the main adverse effect of antiangiogenic therapy frequently limiting the doses of angiogenesis inhibitors, although it is also considered as a possible surrogate marker of the effectiveness of targeted therapy. In 2022, the recommendations of the European Society of Cardiology on the prevention and correction of cardiotoxicity of antitumor therapy were published. The article reviews the current diagnosis and treatment of arterial hypertension induced by antiangiogenic medicines.","PeriodicalId":10353,"journal":{"name":"Clinical pharmacology and therapy","volume":"60 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84642697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Principles of effective management of neuropathic pain in primary care 初级保健中神经性疼痛的有效管理原则
Clinical pharmacology and therapy Pub Date : 2023-05-21 DOI: 10.32756/0869-5490-2023-2-37-42
O. S. Davydov
{"title":"Principles of effective management of neuropathic pain in primary care","authors":"O. S. Davydov","doi":"10.32756/0869-5490-2023-2-37-42","DOIUrl":"https://doi.org/10.32756/0869-5490-2023-2-37-42","url":null,"abstract":"Neuropathic pain caused by disease or damage affecting the somatosensory nervous system is a common problem in the primary care patients. Neuropathic pain can occur in postherpetic neuralgia, Guillain-Barré syndrome, neuroborreliosis, painful diabetic neuropathy, rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, Sjögren's syndrome, after trauma, due to cancer, stroke, etc. The treatment of neuropathic pain involves a comprehensive multimodal approach using pharmacotherapy with antidepressants and anticonvulsants, the most convenient of which is gabapentin, pathogenetic therapy of the underlying disease and non-pharmacological methods. Only integrated approach can provide effective therapy and improve the quality of life of patients with neuropathic pain.","PeriodicalId":10353,"journal":{"name":"Clinical pharmacology and therapy","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84104096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of direct-acting antivirals in patients with HCV-associated cryoglobulinemia and monoclonal gammapathy 直接抗病毒药物治疗丙型肝炎相关冷球蛋白血症和单克隆γ病的疗效
Clinical pharmacology and therapy Pub Date : 2023-05-21 DOI: 10.32756/0869-5490-2023-2-15-20
S. Gavrisheva, D. Abdurakhmanov, N. Bulanov, E. Tanaschuk, T. Rozina, E. Nikulkina, S. Milovanova, A. Filatova, T. Krasnova, E. Starostina, V. Avdeev, P. Novikov, S. Moiseev
{"title":"Efficacy of direct-acting antivirals in patients with HCV-associated cryoglobulinemia and monoclonal gammapathy","authors":"S. Gavrisheva, D. Abdurakhmanov, N. Bulanov, E. Tanaschuk, T. Rozina, E. Nikulkina, S. Milovanova, A. Filatova, T. Krasnova, E. Starostina, V. Avdeev, P. Novikov, S. Moiseev","doi":"10.32756/0869-5490-2023-2-15-20","DOIUrl":"https://doi.org/10.32756/0869-5490-2023-2-15-20","url":null,"abstract":"To evaluate the efficacy of direct-acting antivirals (DAA) in patients with hepatitis C virus (HCV) associated cryoglobulinemia and monoclonal gammapathy (MG).","PeriodicalId":10353,"journal":{"name":"Clinical pharmacology and therapy","volume":"82 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76102065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacoepidemiologic study of antipsychotics safety 抗精神病药物安全性的药物流行病学研究
Clinical pharmacology and therapy Pub Date : 2023-05-21 DOI: 10.32756/0869-5490-2023-2-66-72
V. Skryabin, A. Masyakin, S. Nazimova, D. Sosin, A. Khannanova, V. Shipitsyn, M. Zastrozhin, D. Sychev
{"title":"Pharmacoepidemiologic study of antipsychotics safety","authors":"V. Skryabin, A. Masyakin, S. Nazimova, D. Sosin, A. Khannanova, V. Shipitsyn, M. Zastrozhin, D. Sychev","doi":"10.32756/0869-5490-2023-2-66-72","DOIUrl":"https://doi.org/10.32756/0869-5490-2023-2-66-72","url":null,"abstract":"To analyse spontaneous reports (SRs) of adverse drug reactions (ADRs) related to antipsychotics in Russia.","PeriodicalId":10353,"journal":{"name":"Clinical pharmacology and therapy","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85539918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumour necrosis factor receptor-associated periodic syndrome (TRAPS) 肿瘤坏死因子受体相关周期性综合征
Clinical pharmacology and therapy Pub Date : 2023-05-21 DOI: 10.32756/0869-5490-2023-2-43-50
V. Rameev, L. Lysenko (Kozlovskaya), S. Salugina, N. Chebotareva, N. Bulanov, A. Novikov, M. Barsuk, S. Moiseev
{"title":"Tumour necrosis factor receptor-associated periodic syndrome (TRAPS)","authors":"V. Rameev, L. Lysenko (Kozlovskaya), S. Salugina, N. Chebotareva, N. Bulanov, A. Novikov, M. Barsuk, S. Moiseev","doi":"10.32756/0869-5490-2023-2-43-50","DOIUrl":"https://doi.org/10.32756/0869-5490-2023-2-43-50","url":null,"abstract":"Tumour necrosis factor receptor-associated periodic syndrome (TRAPS) belongs to a group of rare hereditary autoinflammatory diseases (familial periodic fevers). TRAPS is characterized by the periodic occurrence of fever, abdominal pain, maculopapular rash, arthralgia/myalgia and laboratory signs of inflammation that persisit for 5 days to 3 weeks. AAamyloidosis can complicate persisting autoinlammation in TRAPS. The authors report two cases of TRAPS and discuss its diagnosis and treatment.","PeriodicalId":10353,"journal":{"name":"Clinical pharmacology and therapy","volume":"39 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81068305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complement inhibition therapy in patients with atypical hemolytic uremic syndrome and secondary microangiopathies 补体抑制治疗在非典型溶血性尿毒症综合征和继发性微血管病变患者中的应用
Clinical pharmacology and therapy Pub Date : 2023-05-21 DOI: 10.32756/0869-5490-2023-2-7-14
Y. Korotchaeva, N. Kozlovskaya, S. Moiseev
{"title":"Complement inhibition therapy in patients with atypical hemolytic uremic syndrome and secondary microangiopathies","authors":"Y. Korotchaeva, N. Kozlovskaya, S. Moiseev","doi":"10.32756/0869-5490-2023-2-7-14","DOIUrl":"https://doi.org/10.32756/0869-5490-2023-2-7-14","url":null,"abstract":"Atypical hemolytic uremic syndrome (aHUS) is a rare form of thrombotic microangiopathy (TMA) caused by uncontrolled complement activation and leading to thrombocytopenia, microangiopathic hemolysis and acute kidney injury. Eculizumab, a humanized monoclonal antibody that inhibits the cleavage of complement protein C5, effectively reverses laboratory evidence of TMA and improves kidney function in most patients with aHUS. Hereditary aHUS should be differentiated from the secondary HUS associated with drugs, autoimmune diseases (e.g. antiphospholipid syndrome), malignancies, infections, solid organ transplantation. Case reports and retrospective studies suggest that eculizumab may be effective in a proportion of patients with secondary TMA, although its efficacy and regimens of administration should be evaluated in additional studies.","PeriodicalId":10353,"journal":{"name":"Clinical pharmacology and therapy","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81896391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of pharmacokinetics and drug-drug interactions of melatonin and memantine as components of the new original combination drug Miladean® 褪黑素和美金刚作为新组合药物Miladean®的药代动力学和药物相互作用的研究
Clinical pharmacology and therapy Pub Date : 2023-05-21 DOI: 10.32756/0869-5490-2023-2-59-65
A. Goncharov, A. Grigoriev, A. Globenko, I. Goncharov, K. A. Muratov, A. Sidorova, A. A. Nikitin, A. Kapashin, O. Kovchan, A. I. Bashkatova, M. Pasko
{"title":"Investigation of pharmacokinetics and drug-drug interactions of melatonin and memantine as components of the new original combination drug Miladean®","authors":"A. Goncharov, A. Grigoriev, A. Globenko, I. Goncharov, K. A. Muratov, A. Sidorova, A. A. Nikitin, A. Kapashin, O. Kovchan, A. I. Bashkatova, M. Pasko","doi":"10.32756/0869-5490-2023-2-59-65","DOIUrl":"https://doi.org/10.32756/0869-5490-2023-2-59-65","url":null,"abstract":"To compare pharmacokinetics and evaluate drug-drug interactions of the studied drug Miladean® oral dispersible tablets 3 mg + 5 mg (JSC Valenta Pharm, Russia) and reference products Akatinol Memantine 10 mg film-coated tablets (Merz Pharma GmbH & Co. KGaA, Germany) and Melaxen 3 mg film-coated tablets (Unipharm Inc., USA).","PeriodicalId":10353,"journal":{"name":"Clinical pharmacology and therapy","volume":"32 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91106969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeted treatment challenges in patients with adult-onset Still’s disease 成人发病斯蒂尔氏病患者的靶向治疗挑战
Clinical pharmacology and therapy Pub Date : 2023-05-21 DOI: 10.32756/0869-5490-2023-2-51-58
A. Zavrazhnova, E. Kuvardin, V. Myachikova, A. Khadgidis, N. Anokhina, M. Anriyanova, Y. Kozlova, A. Maslyanskiy
{"title":"Targeted treatment challenges in patients with adult-onset Still’s disease","authors":"A. Zavrazhnova, E. Kuvardin, V. Myachikova, A. Khadgidis, N. Anokhina, M. Anriyanova, Y. Kozlova, A. Maslyanskiy","doi":"10.32756/0869-5490-2023-2-51-58","DOIUrl":"https://doi.org/10.32756/0869-5490-2023-2-51-58","url":null,"abstract":"Adult-onset Still’s disease (AOSD) is a systemic autoinflammatory disease mediated by interleukin (IL)-1 production. There are no treatment guidelines for AOSD due to its rarity and heterogenous manifestations. Therefore, each case is challenging and requires a multidisciplinary approach. We report a case of AOSD occurring in pregnant patient who did not respond to standard treatment with glucocorticoids and developed skin reaction to IL-1 receptor antagonist. However, drug desensibilisation was effective and allowed to continue treatment with anakinra.","PeriodicalId":10353,"journal":{"name":"Clinical pharmacology and therapy","volume":"68 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88055762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fabry disease in female patients: clinical features, outcomes and indications for enzyme replacement therapy 法布里病在女性患者:临床特点，结果和适应症的酶替代治疗
Clinical pharmacology and therapy Pub Date : 2023-05-21 DOI: 10.32756/0869-5490-2023-2-27-31
S. Moiseev, N. Bulanov, A. Moiseev, E. Tao, V. Sholomova, D. Ismailova, E. Mershina
{"title":"Fabry disease in female patients: clinical features, outcomes and indications for enzyme replacement therapy","authors":"S. Moiseev, N. Bulanov, A. Moiseev, E. Tao, V. Sholomova, D. Ismailova, E. Mershina","doi":"10.32756/0869-5490-2023-2-27-31","DOIUrl":"https://doi.org/10.32756/0869-5490-2023-2-27-31","url":null,"abstract":"To evaluate clinical features and indications for enzyme replacement therapy (ERT) in female patients with Fabry disease (FD) in the Russian population.","PeriodicalId":10353,"journal":{"name":"Clinical pharmacology and therapy","volume":"94 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74846244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信